Loading news...
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Merit Medical (MMSI) and Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Merit Medical Systems, Inc. (NASDAQ: MMSI - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday after Wells Fargo and Company downgraded the stock from an overweight rating to an equal weight rating. Wells Fargo and Company now has a $78.00 price target on the stock, down from their previous
Pre-Market Stock Futures: The futures are trading flat after a big follow-through rally on Wednesday, which fed off the big gains generated on Tuesday. The big news after the closing bell was the Nvidia earnings release. While they once again blew out the numbers, Wall Street initially didn't take it as a sign for a... Here Are Thursday's Top Wall Street Analyst Research Calls: Alcon, First Solar, Five Below, Joby Aviation, Spotify, Trade Desk, U.S. Bancorp, and More.
MMSI beats Q4 estimates as EPS climbs 12% and margins widen, driven by strong Cardiovascular growth and solid U.S. and EMEA sales.
Merit Medical Systems, Inc. (MMSI) Q4 2025 Earnings Call Transcript
Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Merit Medical (MMSI) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.93 per share a year ago.
Merit Medical Systems (NASDAQ: MMSI - Get Free Report) and STAAR Surgical (NASDAQ: STAA - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Analyst Ratings This is a summary of
Envestnet Asset Management Inc. increased its position in shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) by 10.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 269,189 shares of the medical instruments supplier's stock after acquiring an additional 25,026 shares during
Shares of Merit Medical Systems, Inc. (NASDAQ: MMSI - Get Free Report) have received a consensus rating of "Moderate Buy" from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Merit Medical (MMSI) and Straumann Holding AG (SAUHY). But which of these two companies is the best option for those looking for undervalued stocks?
The mean of analysts' price targets for Merit Medical (MMSI) points to a 26.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Pre-Market Stock Futures: Futures are trading higher as we prepare to wrap up one of the worst trading weeks in some time. The song remains the same as the rotation out of the tech trade continues to gain strength. Toss in the weakness in cryptocurrencies, along with a renewed skepticism towards the asset, and the... Here Are Friday's Top Wall Street Analyst Research Calls: Amazon.com, Caterpillar, Estee Lauder, JPMorgan, Norfolk Southern, Roku, Snap, Vistra, and More.
MMSI's WRAPSODY reimbursement tailwinds, expanding high-margin portfolio and strong cash flow set up growth into 2026 despite macro and forex headwinds.
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Emerald Advisers LLC reduced its stake in shares of Merit Medical Systems, Inc. (NASDAQ: MMSI) by 3.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 280,622 shares of the medical instruments supplier's stock after selling 11,168 shares
Merit Medical Systems, Inc. (MMSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit's Lead Independent Director, as Chair of the Board effective January 5, 2026.